Internal Medicine, Medical Oncology · Minneapolis, MN
NPI
1386670297
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
9
Medicare group memberships
Hospitals
5
Hospital affiliations
909 Fulton St SE
Minneapolis, MN, 55455
Phone (612) 625-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
314 services
Medicare patients, 2024
80
Average age 71
Drug cost, 2024
$1.5M
526 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward W Greeno was code 99215 (office e&m - established), 82 times for 34 patients. In total Edward W Greeno billed 314 services in 16 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 82 | 34 | $135.37 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 24 | $12.51 | $488 |
| 99215 Office E&M - Established | Facility | 30 | 19 | $108.90 | $3,267 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 29 | 23 | $12.54 | $364 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 25 | 13 | $24.60 | $615 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 25 | 14 | $23.60 | $590 |
| 99214 Office E&M - Established | Office | 24 | 20 | $96.86 | $2,325 |
| 99214 Office E&M - Established | Facility | 18 | 12 | $69.36 | $1,248 |
| 99205 Office E&M - New | Facility | 12 | 12 | $136.25 | $1,635 |
By year: 2022 $21K for 512 services; 2023 $17K for 229 services; 2024 $23K for 314 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward W Greeno prescribed most often to Medicare patients was Ondansetron Hcl, with 44 prescriptions and refills. In total Edward W Greeno wrote 526 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 44 | 44 | 23 | $316 |
| Imatinib Mesylate Generic | 38 | 50 | Under 11 | $9,499 |
| Prochlorperazine Maleate Generic | 35 | 35 | 23 | $418 |
| Xarelto Rivaroxaban | 28 | 42 | Under 11 | $24K |
| Creon Lipase/Protease/Amylase | 28 | 39 | Under 11 | $114K |
| Loperamide Loperamide Hcl | 27 | 27 | 12 | $546 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | Under 11 | $426 |
| Dexamethasone Generic | 24 | 24 | 11 | $91.65 |
| Lonsurf Trifluridine/Tipiracil Hcl | 21 | 21 | Under 11 | $444K |
| Eliquis Apixaban | 17 | 19 | Under 11 | $11K |
| Omeprazole Generic | 16 | 30 | Under 11 | $164 |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $189 |
| Sorafenib Sorafenib Tosylate | 14 | 14 | Under 11 | $86K |
| Gabapentin Generic | 13 | 13 | Under 11 | $166 |
| Potassium Chloride Generic | 13 | 23 | Under 11 | $230 |
Brand drugs: 154 claims; generic drugs: 372 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward W Greeno $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.